Medicare Enrolled

Dr. Danny Benmoshe, M.D.

Neurology · Santa Monica, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
2001 SANTA MONICA BLVD, Santa Monica, CA 90404
8189436635
In practice since 2007 (18 years)
NPI: 1336330141 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Benmoshe from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Benmoshe? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Benmoshe

Dr. Danny Benmoshe is a neurology specialist in Santa Monica, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Benmoshe performed 1,552 Medicare services across 849 unique beneficiaries.

Between the years covered by Open Payments, Dr. Benmoshe received a total of $200,112 from 75 pharmaceutical and/or device companies across 965 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Benmoshe is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 24% volume in CA $200,112 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,552
Medicare services
Top 24% in CA for neurology
849
Unique beneficiaries
$150
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~86 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
785 $145 $498
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
214 $88 $325
New patient office visit, complex (60-74 min) 209 $181 $699
Neurobehavioral status exam, first hour
A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions.
85 $78 $200
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
78 $27 $51
Nerve conduction studies, 13 or more
A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed.
77 $253 $1,050
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
72 $413 $1,500
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
17 $100 $350
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
15 $144 $675
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$200,112
Total received (2018-2024)
Avg $28,587/year across 7 years
Top 4% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
75
Companies
965
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$178,376 (89.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,130 (6.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,605 (4.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$72,406
2023
$23,730
2022
$21,447
2021
$48,293
2020
$29,804
2019
$2,447
2018
$1,983

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Eisai Inc.
$54,151
Lilly USA, LLC
$16,766
ABBVIE INC.
$321
Lundbeck LLC
$274
PFIZER INC.
$89
ARGENX US, INC.
$69
ACADIA Pharmaceuticals Inc
$67
Neurelis, Inc.
$66
Kyowa Kirin, Inc.
$66
Teva Pharmaceuticals USA, Inc.
$64
SK Life Science, Inc.
$57
MDD US Operations, LLC
$51
Ipsen Biopharmaceuticals, Inc
$51
Biogen, Inc.
$50
Alnylam Pharmaceuticals Inc.
$46
UCB, Inc.
$43
Acorda Therapeutics, Inc
$40
Amneal Pharmaceuticals LLC
$37
MITSUBISHI TANABE PHARMA AMERICA, INC.
$26
Otsuka America Pharmaceutical, Inc.
$22
Takeda Pharmaceuticals U.S.A., Inc.
$19
Neurocrine Biosciences, Inc.
$18
Abbott Laboratories
$14
Top 3 companies account for 98.4% of 2024 payments
All-time payments by company (2018-2024) ›
Eisai Inc.
$62,387
Allergan, Inc.
$34,462
AbbVie Inc.
$31,055
Lilly USA, LLC
$23,469
Biohaven Pharmaceuticals, Inc.
$19,673
ABBVIE INC.
$11,301
Biogen, Inc.
$4,437
Biohaven Pharmaceutical Holding Company Ltd.
$2,291
Amgen Inc.
$1,699
Lundbeck LLC
$780
US WorldMeds, LLC
$598
Allergan Inc.
$590
Teva Pharmaceuticals USA, Inc.
$574
PFIZER INC.
$490
Upsher-Smith Laboratories LLC
$422
UPSHER-SMITH LABORATORIES LLC
$391
Acorda Therapeutics, Inc
$368
IMPEL PHARMACEUTICALS INC.
$301
Mallinckrodt Hospital Products Inc.
$253
UCB, Inc.
$250
Neurelis, Inc.
$239
Neurocrine Biosciences, Inc.
$223
ACADIA Pharmaceuticals Inc
$213
Genentech USA, Inc.
$192
Promius Pharma LLC
$188
SK Life Science, Inc.
$172
MITSUBISHI TANABE PHARMA AMERICA, INC.
$170
Novartis Pharmaceuticals Corporation
$165
MDD US Operations, LLC
$163
EMD Serono, Inc.
$149
Alnylam Pharmaceuticals Inc.
$136
JAZZ PHARMACEUTICALS INC.
$125
Alexion Pharmaceuticals, Inc.
$121
Kyowa Kirin, Inc.
$120
Akcea Therapeutics, Inc.
$120
Amneal Pharmaceuticals LLC
$112
Otsuka America Pharmaceutical, Inc.
$104
Abbott Laboratories
$87
Nevro Corp.
$86
Avanir Pharmaceuticals, Inc.
$84
NOVARTIS PHARMACEUTICALS CORPORATION
$75
Ipsen Biopharmaceuticals, Inc
$74
Horizon Therapeutics plc
$71
ARGENX US, INC.
$69
Impax Laboratories, Inc.
$68
Takeda Pharmaceuticals U.S.A., Inc.
$65
Janssen Pharmaceuticals, Inc
$58
Zyla Life Sciences, Inc.
$52
Boston Scientific Corporation
$51
Supernus Pharmaceuticals, Inc.
$48
CATALYST PHARMACEUTICALS, INC.
$47
TerSera Therapeutics LLC
$46
TG THERAPEUTICS, INC.
$42
Assertio Therapeutics, Inc.
$40
Neuronetics, Inc.
$36
GRT US Holding, Inc.
$36
Mitsubishi Tanabe Pharma America, Inc.
$35
Merz North America, Inc.
$34
Egalet US Inc
$34
Merz Pharmaceuticals, LLC
$31
ANI Pharmaceuticals, Inc.
$30
Life Molecular Imaging Ltd
$29
Cala Health, Inc.
$27
Mallinckrodt Enterprises LLC
$26
Medtronic Vascular, Inc.
$25
EISAI INC.
$24
Travere Therapeutics, Inc.
$24
Adamas Pharmaceuticals, Inc.
$22
Linus Health, Inc.
$22
Collegium Pharmaceutical, Inc.
$22
Otsuka Pharmaceutical Development & Commercialization, Inc.
$21
ASSERTIO THERAPEUTICS, Inc.
$21
GENZYME CORPORATION
$18
CSL Behring
$17
Itamar Medical Inc
$14
Top 3 companies account for 63.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · APOKYN · AUSTEDO · Aimovig · Austedo XR · BOTOX · BOTOX - NEUROLOGY · BOTOX COSMETIC · BOTOX THERAPEUTIC · BRIUMVI · Briviact · CALA TRIO · CAMBIA · COMIRNATY · CORE COGNITIVE EVALUATION · CREXONT · Cholbam · Dysport · ELYXYB - celecoxib · EMGALITY · ETERNA · Enbrel · FIRDAPSE · Fycompa · GAMMAGARD · GENERAL DBS · GILENYA · GOCOVRI · Gocovri · Gralise · HYQVIA · Hizentra · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · Leqembi · MYOBLOC · NEURACEQ · NEUROSTAR TMS THERAPY SYSTEM · NUEDEXTA · NUPLAZID · NURTEC ODT · Neuromodulation Dspsbls and Accs · Nourianz · Nuedexta · OCREVUS · ONPATTRO · Ocrevus · Ongentys · PAXLOVID · PRIALT · PURIFIED CORTROPHIN GEL · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Qutenza · RADICAVA · REXULTI · RYTARY · Radicava · Reveal LINQ · Rystiggo · SOLIRIS · SPRIX · Senza Spinal Cord Stimulation System · Soliris · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · Trudhesa · UBRELVY · UPLIZNA · VALTOCO · VRAYLAR · VUMERITY · VYEPTI · VYVGART HYTRULO · WatchPATONE · XADAGO · XEOMIN · Xadago · Xeomin · ZAVZPRET · ZEMBRACE SYMTOUCH · Zembrace · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (89%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for neurology in CA.

Looking for a neurology specialist in Santa Monica?
Compare neurologists in the Santa Monica area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
516
Per 100K population
5.2
County median income
$87,760
Nearest hospital
SANTA MONICA - UCLA MED CTR & ORTHOPAEDIC HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Benmoshe is a clinical cardiology specialist, with above-average Medicare volume (top 24% in CA), with speaking/promotional industry engagement in the top 4% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Benmoshe experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Benmoshe performed 785 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Benmoshe receive payments from pharmaceutical companies?
Yes. Dr. Benmoshe received a total of $200,112 from 75 companies across 965 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Benmoshe's costs compare to other neurologists in Santa Monica?
Dr. Benmoshe's average Medicare payment per service is $150. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Benmoshe) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →